SCANORTO A/S: Financial statements 2025
CVR: 12687648
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
SCANORTO A/S (CVR 12687648) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 12,395,453 and a net result of DKK 1,917,702 compared with DKK 1,654,974 the year before. That is a decrease of 3% compared with the year before. Equity in the 2025 report amounted to DKK 12,950,705. The solvency ratio was 42.8%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 12,395,453
- Profit/Loss
- DKK 1,917,702
- Equity
- DKK 12,950,705
- Total Assets
- DKK 30,270,089
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 12.4 mio. | 1.9 mio. | 13 mio. | 12 |
| 2024 | - | 12.8 mio. | 1.7 mio. | 11 mio. | 12 |
| 2023 | - | 15.8 mio. | 1.5 mio. | 9.4 mio. | 14 |
| 2022 | - | 14.7 mio. | 861 t. | 7.9 mio. | 13 |
| 2021 | - | 12.7 mio. | 532 t. | 7.1 mio. | 13 |
Official annual report
How creditworthy is SCANORTO A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
SCANORTO A/S has published its annual report for 2024. Gross profit came to DKK 12,777,070, and the net result was DKK 1,654,974.
SCANORTO A/S has won the tender "Levering af materialer til tandregulering" issued by Aarhus Kommune worth 6,312,085 DKK.
As of February 3, 2025, Karel Rajchert has joined the board of directors of SCANORTO A/S.
As of February 3, 2025, Steven Schwarz has left the board of directors of SCANORTO A/S.
As of February 3, 2025, Karel Rajchert is registered as director of SCANORTO A/S.
As of February 3, 2025, Steven Schwarz has stepped down as adm. dir. of SCANORTO A/S.
About SCANORTO A/S
SCANORTO A/S is a Danish company of the type Aktieselskab based in Kgs. Lyngby, founded in 1989. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named LASSE LAGER HOLDING ApS and ASX 14746 ApS. The management consists of Karel Rajchert. The board consists of Karel Budka (chair), Filipa Alexandra Pinto De Almeida and Karel Rajchert. The company is owned by NOBEL BIOCARE DANMARK A/S. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 12,395,453 and a net result of DKK 1,917,702 compared with DKK 1,654,974 the year before. Equity in the 2025 report amounted to DKK 12,950,705.